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Conclusions: We report here for the first time measurements 
of DNA damage with pulsed protons at ultrahigh dose rate 
(109-1010 Gy/s) under hypoxic conditions.  
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We have used the calorimeter module originally designed for 
the SuperNEMO experiment to measure the energies of 
protons at the Clatterbridge proton therapy cyclotron. 
Such measurements are necessary for time consuming QA 
checks, and by improving the rates and energy resolution this 
time can be considerably reduced.  
Preliminary results show that an energy resolution of sigma 
0.7% can be achieved for low rates which will later be 
compared to the high rate data. We hope to extend this 
technique to proton radiography as well. 
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Introduction: Cancer treatment by radiotherapy is a complex 
process and needs accurate radiation treatment delivery and 
can be verified using in vivo measurements. Optically 
stimulated luminescence dosimeter [OSLD] has been used 
extensively for beam dosimetry, radiation protection 
including in vivo measurements due to their simple readout 
process and multiple times readout facility.  
Aim and Objective: The aim of the present work is to study 
the dosimetric characteristics of commercial OSL system by 
Landauer Inc. before using it for clinical practice in 
radiotherapy. 
Material and Methods: The OSLD system used is a commercial 
InLightTM microstar reader system, manufactured by Landauer 
Inc. The detector consist of Al2O3:C nanodot as OSL material, 
enveloped in special light protective plastic holders. In the 
present study the irradiations are carried out in 30*30 cm2 
solid water slab phantoms. Bhabhatron – II cobalt 60 
telecobalt radiation is used for most of the measurements 
carried out. Clinac – iX is also used for 6 MV and 10MV energy 
photon beams to study dose rate and energy dependence. 
Absolute dose is measured using a 30013 PTW ionization 
chamber in solid water and compared with OSL dosimeter 
measurements. 
Unless otherwise mentioned, all irradiations carried out using 
an SSD setup (80cm for co-60 and 100cm for linac) with 
10*10cm2 field size.OSL response with given dose is 
investigated for doses ranging from 0.5 to 4Gy. Energy 
dependence of OSL is investigated for Co-60, 6MV, 10MV 
beams, delivering a dose of 50 cGy each. Further the dose 
rate dependence of OSL detector is evaluated for dose rates 
of 200, 400, 600 cGy/min in accelerator with 6MV energy 
beam. We also studied the field size dependence by 
irradiating OSLD chips to 50 cGy dose for various field sizes 
ranging from 4*4 to 35*35 cm2 for cobalt -60 beam. The 
dosimeter angular response is studied at various gantry 
angles from 90º to 270º, at an interval of 30º, with and 
without build up respectively. 
Results: In present study it was observed that the OSL dose 
deviation is about - 4.5% as compared with ionization 
chamber. Further the reproducibility of detector is found to 
be within 3.44% standard deviation, with COV 0.035. There is 
no significant energy dependence of Al2O3:C detector for the 
energy range Co-60 to 10MV. The detector response was 
found to be linear in the dose range of 0.5 to 4Gy. The 
detector response is almost independent in clinical dose rate 
range, nearly independent of field size and is independent to 
angle of incidence of beam.  
Discussion: The dosimetric characteristics of OSL system were 
studied and found that OSL response is energy and dose rate 
independent. The stability of system and linear dose 
response relationship makes it a good dosimeter for in vivo 
dosimetry in clinical radiotherapy.  
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Background: Air filled ionization chambers are the dosimeters 
of choice for photon therapy as well as particle therapy. 
Dosimetry protocols for ion beams take recombination effects 
into account, where the generated charge in the ionization 
chamber may recombine before it is picked up by the 
electrode. It is well established that intra-track 
recombination (initial recombination) is negligible in medical 
photon and electron beams, but must be accounted for in 
beams with heavy ions. However, the underlying assumptions 
for establishing the recommended method for correction for 
inter-track recombination (general recombination) still 
remains unclear today [1]. The current two-voltage method 
only is applicable for low LET-beams, with no initial 
recombination present [2,3], and this progress report focuses 
on a detailed recombination study of ion beams. 
Here, we calculate the columnar recombination when the ion 
track is 
• parallel to the electric field 
• rotated with an angle between 0 and 𝜋𝜋/2 relative 
to the external field which was estimated 
analytically by Jaffé [4] and later confirmed 
experimentally by Kanai et al [5].  
The general recombination is investigated by 
• sampling two parallel ion tracks at different 
separation and initialized at different times 
• comparing the simulation of a continuous beam 
with Greening’s formula [6] for collection 
efficiency.  
Simulations are confirmed by comparison with experimental 
data.  
Methods: We have investigated positive and negative charge 
carrier distributions (CCDs) by solving the differential 
equation using a finite difference approach, 
 
with  derived from the initial CCDs,  the diffusion 
constant,  the mobility, for positive and negative CCDs, 
E  the electric field vector, and the recombination 
constant. 
Results: Our simulations reproduced the analytical solution 
from Jaffé and the experimental results by Kanai et al. On 
this platform we could also verify the Greening analytical 
solution.  
Conclusion: The simulations of pulsed and continuous beams 
are seen to agree well with the known theories and 
experimental data, and the program is thus capable of 
reproducing the initial and general recombination processes 
taking place in high LET-beams. This allows a deeper study of 
the actual recombination processes taking place when 
several ion tracks are present and ultimately account for the 
overall recombination in air filled ionization chambers 
irradiated with high LET-beams. 
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Background:  The anti-CTLA4 antibody, ipilumumab (ipi), 
improves survival in metastatic melanoma. With increased 
survival and improved extracranial control, a greater 
proportion of melanoma patients develop brain metastases. 
The effects of combining radiotherapy (RT), whole brain RT 
(WBRT) or stereotactic radiosurgery (SRS) with Ipi are 
unclear.  This study reports the incidence and factors 
associated with acute radiation effect (ARE), in patients with 
melanoma brain metastases treated with ipi and brain RT.  
Methods:  All patients with melanoma brain metastases who 
received WBRT or SRS and ipi at our institution from 2008-
2014 were included. Outcome measures included incidence 
of ARE, treatment response, progression free survival (PFS) 
and overall survival (OS). Variables included baseline patient 
characteristics, type of RT (WBRT or SRS), dosimetric 
parameters (including V12 Gy for SRS), time between RT and 
ipi treatment. Using our prospective brain metastases 
database, incidence of ARE was compared against patients 
treated with SRS alone at our institution. 
Results:   A total of 688 patients in our database received SRS 
upfront and 54 pts met eligibility for evaluation of RT and ipi 
of which 34 were evaluable (20 were excluded due to lack of 
follow up imaging). With a median follow up of 7.4 months, 
OS was 6.4 months and PFS was 2.7 months. In patients 
treated with WBRT alone, no ARE was seen. In those who 
received SRS with ipi, 11/27 (41%) patients developed ARE. 
Of these, 7 patients had received RT within 4 months of ipi 
(SRS = 4, SRS+WBRT = 3) and 4 received RT outside of this 
window (SRS = 2, SRS+WBRT= 2). Out of the 688 patients 
treated with upfront SRS, 11% developed ARE.  Larger tumor 
volume and higher V12Gy were associated with a higher rate 
of ARE. A total of 6 patients received steroids for 
symptomatic ARE of which only 1 patient did not respond and 
required surgical intervention. The pathology showed treated 
melanoma along with necrosis, and predominantly 
inflammatory T cells and macrophages.  
Conclusions:  The incidence of ARE was greater in patients 
treated with SRS and ipi (41%) compared to SRS alone (10%). 
In contrast, no ARE was seen after WBRT and ipi. In the 
majority of cases, symptomatic ARE responded to steroids. In 
1 case requiring surgery, pathology demonstrated an 
increased immunological effect.  
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Radiotherapy with external photon or electron beams 
represents one of the most widespread methods in the 
treatment of cancer disease. Recently the irradiation 
techniques have reached an accuracy of few mm. Intensity-
Modulated-Radiation-Therapy (IMRT) is one of the most 
advanced irradiation techniques with external X-ray beams. 
It allows to conform in more detail the beam to the tumor 
volume adjusting a set of programmable multi-leaf collimator 
which can assume very different shapes. Then a very 
accurate instrument is required to verify the real released 
doses. Pre-treatment quality assurance play a central role in 
a typically radiotherapy treatment session because 
guarantees the success the treatment.  
Devices devoted to quality assurance are dosimeter with 
different forms and dimensions. An important category is 
represented by 2D devices which are able to provide a 
measure of the dose distribution on a given area. The most 
common are ionization chamber arrays, films and Electronic 
Portal Imaging Devices (EPID). All these devices presents 
some drawbacks which limit their performance like 2D 
dosimeters, especially for IMRT. Ionization chamber arrays 
have a spatial resolution limited to few mm. Film dosimeters, 
on the contrary, can provide an higher spatial resolution with 
the drawback that it must be processed after taking into 
account other parameters which can influence the correct 
dose measure like fading, UV sensitivity, temperature and so 
on. EPID is applied as a 2D dosimeter, but an algorithm 
software is needed to convert the registered signal by an 
EPID into dose values and it is difficult to realize a unique 
software devoted to this aim. 
The present work will demonstrate that detectors based on 
the Gas Electron Multiplier (GEM) technology [1] with a 
medipix C-MOS read-out can be a valid alternative for 2D 
dosimetry respect to the traditional devices. This type of 
detector, called “GEMpix” [2], shows some interesting 
characteristics which can overcome the typical drawbacks 
observed in the traditional 2D dosimeters [3]. In particular 
the GEMpix, working in a bi-GEM configuration, can perform 
2D real time dose distribution measurements with a spatial 
resolution comparable the gafchromic films. A comparison 
between GEMpix and gafchromics has been performed in 
order to test its ability to work as 2D dosimeter. Dose 
matching between the two dosimeters has been evaluated 
applying a the gamma-index test analysis with the commonly 
accepted criteria of distance to agreement < 3 mm  and dose 




The figure shows a particular dose distribution as measured 
by GEMpix and by a gafchromic film. In the third panel a 
gamma index test map shows the areas where gamma index 
is less 1. This is verified in the 90,5 % of points. 
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